Xavier Badia
Research Subjects
Xavier Badia has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Adolfo Diez-Perez
Department of Internal Medicine, Hospital del Mar-IMIM, Autonomous University of Barcelona and CIBERFES, Instituto Carlos III, Barcelona, Spain
2 shared publications - Eric Myon
Pierre Fabre SA, 45 place Abel Gance, 92654 Boulogne-Billancourt Cedex, France
2 shared publications - Farid Saad
GBU Gynecology-Andrology, Bayer Schering Pharma, Berlin, Germany
2 shared publications - John Slof
Department of Business, Universitat Autònoma de Barcelona, Bellaterra, Spain 5
2 shared publications Juan del Llano
2 shared publications- Lothar A. J. Heinemann
Centre for Epidemiology & Health Research Berlin, Invalidenstr. 115, 10115 Berlin, Germany
2 shared publications
Latest Publications
- Open Access
- 1 August 2006
- Published by Elsevier in Actas Urológicas Españolas
- Vol. 30 (7) , 667-674
Validez de las pruebas utilizadas en el diagnóstico inicial y su concordancia con el diagnóstico final en pacientes con sospecha de hiperplasia benigna de próstata
- 1 August 2006
- Published by Elsevier in Actas Urológicas Españolas
- Vol. 30 (7) , 667-674
Open AccessValidez de las pruebas utilizadas en el diagnóstico inicial y su concordancia con el diagnóstico final en pacientes con sospecha de hiperplasia benigna de próstata
- 30 April 2006
- Published by Elsevier in Medicina Clinica
- Vol. 126 (14) , 537-540
Incidencia y carga sanitaria del íleo paralítico postoperatorio en España
- 30 April 2006
- Published by Elsevier in Medicina Clinica
- Vol. 126 (14) , 537-540
Incidencia y carga sanitaria del íleo paralítico postoperatorio en España
- 1 April 2006
- Published by Springer Nature in PharmacoEconomics Spanish Research Articles
- Vol. 3 (2) , 75-88
Evaluación clínica y económica de la profilaxis con fondaparinux en comparación con enoxaparina en cirugía ortopédica mayor
- 1 April 2006
- Published by Springer Nature in PharmacoEconomics Spanish Research Articles
- Vol. 3 (2) , 75-88
Evaluación clínica y económica de la profilaxis con fondaparinux en comparación con enoxaparina en cirugía ortopédica mayor
- 1 March 2006
- Published by Elsevier in Atencion Primaria
- Vol. 37 (5) , 278-286
Visados de inspección: ¿garantía del uso adecuado de los medicamentos o medida de control del gasto?
- 1 March 2006
- Published by Elsevier in Atencion Primaria
- Vol. 37 (5) , 278-286
Visados de inspección: ¿garantía del uso adecuado de los medicamentos o medida de control del gasto?
- 1 December 2005
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 58 (12) , 1385-1395
Short- and Long-Term Cost-Effectiveness Analysis of Adding Clopidogrel to Standard Therapy in Acute Coronary Syndrome Patients in Spain
- 1 December 2005
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 58 (12) , 1385-1395
Short- and Long-Term Cost-Effectiveness Analysis of Adding Clopidogrel to Standard Therapy in Acute Coronary Syndrome Patients in Spain
- 1 June 2005
- Published by Elsevier in Atencion Primaria
- Vol. 36 (2) , 93-99
Información de medicamentos de prescripción: encuesta a la población general española
- 1 June 2005
- Published by Elsevier in Atencion Primaria
- Vol. 36 (2) , 93-99
Información de medicamentos de prescripción: encuesta a la población general española
- Open Access
- 7 April 2005
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 3 (1) , 1-24
Combination of qualitative and quantitative methods for developing a new Health Related Quality of Life measure for patients with anogenital warts
Background: Anogenital warts are the most easily recognized sign of genital Human Papilloma Virus infection. The objective was to develop a short, valid and reliable questionnaire to measure Health Related Quality of Life (HRQL) in patients with anogenital warts. Methods: First a literature review was performed to identify relevant papers describing the impact of anogenital warts in HRQL; second the main domains were identified by some experts in a focus group, and third in-depth-semi-structured interviews were conducted in patients with anogenital warts to identify the initial set of items. A qualitative reduction of the initial set of items was performed based on the mean scoring of the experts for the three scales: clarity, frequency and importance. The initial questionnaire was pilot tested in 135 patients. Rasch analysis was performed with the results of the questionnaire in order to refine the instrument. Spearman's correlation was calculated between the initial questionnaire and the reduced version. Additionally the measurement properties (validity and reliability) of the resulting final questionnaire were tested and compared using standard procedures (Cronbach's Alpha and item-total correlation). Results: the main domains identified as affected in patient's life were: sexual, colleagues and partner relationships. After a proper qualitative reduction the initial set of 134 items was reduced to 22. The questionnaire was pilot tested in 135 patients and two dimensions were identified after the multifactorial analysis: emotional dimension and sexual activity dimension. As a result of the Rasch analysis the questionnaire was reduced to 10 items. High correlation was found between the initial and the reduced version for the two dimensions. Cronbach's alpha values were acceptable (0.86). Conclusion: The initial 22 items questionnaire was reduced by Rasch analysis to a version of 10 items, with two dimensions: emotional and sexual. The results suggest the adequacy of the 10 items to evaluate HRQL of patients with anogenital warts in a valid and reliable way.
- 7 April 2005
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 3 (1) , 1-24
Open AccessCombination of qualitative and quantitative methods for developing a new Health Related Quality of Life measure for patients with anogenital warts
Background: Anogenital warts are the most easily recognized sign of genital Human Papilloma Virus infection. The objective was to develop a short, valid and reliable questionnaire to measure Health Related Quality of Life (HRQL) in patients with anogenital warts. Methods: First a literature review was performed to identify relevant papers describing the impact of anogenital warts in HRQL; second the main domains were identified by some experts in a focus group, and third in-depth-semi-structured interviews were conducted in patients with anogenital warts to identify the initial set of items. A qualitative reduction of the initial set of items was performed based on the mean scoring of the experts for the three scales: clarity, frequency and importance. The initial questionnaire was pilot tested in 135 patients. Rasch analysis was performed with the results of the questionnaire in order to refine the instrument. Spearman's correlation was calculated between the initial questionnaire and the reduced version. Additionally the measurement properties (validity and reliability) of the resulting final questionnaire were tested and compared using standard procedures (Cronbach's Alpha and item-total correlation). Results: the main domains identified as affected in patient's life were: sexual, colleagues and partner relationships. After a proper qualitative reduction the initial set of 134 items was reduced to 22. The questionnaire was pilot tested in 135 patients and two dimensions were identified after the multifactorial analysis: emotional dimension and sexual activity dimension. As a result of the Rasch analysis the questionnaire was reduced to 10 items. High correlation was found between the initial and the reduced version for the two dimensions. Cronbach's alpha values were acceptable (0.86). Conclusion: The initial 22 items questionnaire was reduced by Rasch analysis to a version of 10 items, with two dimensions: emotional and sexual. The results suggest the adequacy of the 10 items to evaluate HRQL of patients with anogenital warts in a valid and reliable way.
- 1 January 2005
- Published by Informa Healthcare in Journal of Medical Economics
- Vol. 8 (1-4) , 27-43
Cost-efficacy of oral triptans in the treatment of acute migraine
- 1 January 2005
- Published by Informa Healthcare in Journal of Medical Economics
- Vol. 8 (1-4) , 27-43
Cost-efficacy of oral triptans in the treatment of acute migraine
- Open Access
- 3 August 2004
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 2 (1) , 1-41
The ECOS-16 questionnaire for the evaluation of health related quality of life in post-menopausal women with osteoporosis
Background: The aim of this study is to validate the questionnaire ECOS-16 (Assessment of health related quality of life in osteoporosis) for the evaluation of health related quality of life (HRQoL) in post-menopausal women with osteoporosis. Methods: An observational, prospective and multi-centre study was carried out among post-menopausal women with osteoporosis in primary care centres and hospital outpatient clinics. All patients attended 2 visits: at baseline and at 6 months. In addition, the subgroup of outpatients attended another visit a month after the baseline to assess the test-retest reliability. The psychometric properties of the questionnaire were evaluated in terms of feasibility, validity (content validity and construct validity) and internal consistency in baseline, and in terms of test-retest reliability and responsiveness to change in visit at month and visit at 6 months, respectively. In all visits, ECOS-16, EUROQoL-5D (EQ-5D) and four 7-point items about health status (general health status, back pain, limitation in daily activities and emotional status) were administered, whereas only outpatients were given MINI-OQLQ (Mini Osteoporosis Quality of Life Questionnaire), besides all clinical variables; and sociodemographic variables at baseline. Results: 316 women were consecutively included, 212 from primary care centres and 104 from hospital outpatient clinics. Feasibility: 94.3% of patients answered all items of the questionnaire. The mean administration time was 12.3 minutes. Validity: factor analysis suggested that the questionnaire was unidimensional. In the multivariate analysis, patients with vertebral fractures, co-morbidity and a lower education level showed to have worse HRQoL. Moderate to high correlations were found between the ECOS-16 score and the other health status questionnaires (0.47–0.82). Reliability: internal consistency (Cronbach's α) was 0.92 and test-retest reliability (ICC) was 0.80. Responsiveness to change: ECOS-16 scores increased according to change perceived by the patient, as well as the effect size (ranges between 1.35 to 0.43), the greater the perception of change in patients' general health status, the greater the changes in patients' scores. The Minimal Clinically Important Difference (MCID) suggested a change of 0.5 points in the ECOS-16 score, representing the least improvement in general health status due to their osteoporosis: "slightly better". Conclusion: ECOS-16 has been proven preliminarily to have good psychometric properties, so that it can be potentially a useful tool to evaluate HRQoL of post-menopausal women with osteoporosis in research and routine clinical practice.
- 3 August 2004
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 2 (1) , 1-41
Open AccessThe ECOS-16 questionnaire for the evaluation of health related quality of life in post-menopausal women with osteoporosis
Background: The aim of this study is to validate the questionnaire ECOS-16 (Assessment of health related quality of life in osteoporosis) for the evaluation of health related quality of life (HRQoL) in post-menopausal women with osteoporosis. Methods: An observational, prospective and multi-centre study was carried out among post-menopausal women with osteoporosis in primary care centres and hospital outpatient clinics. All patients attended 2 visits: at baseline and at 6 months. In addition, the subgroup of outpatients attended another visit a month after the baseline to assess the test-retest reliability. The psychometric properties of the questionnaire were evaluated in terms of feasibility, validity (content validity and construct validity) and internal consistency in baseline, and in terms of test-retest reliability and responsiveness to change in visit at month and visit at 6 months, respectively. In all visits, ECOS-16, EUROQoL-5D (EQ-5D) and four 7-point items about health status (general health status, back pain, limitation in daily activities and emotional status) were administered, whereas only outpatients were given MINI-OQLQ (Mini Osteoporosis Quality of Life Questionnaire), besides all clinical variables; and sociodemographic variables at baseline. Results: 316 women were consecutively included, 212 from primary care centres and 104 from hospital outpatient clinics. Feasibility: 94.3% of patients answered all items of the questionnaire. The mean administration time was 12.3 minutes. Validity: factor analysis suggested that the questionnaire was unidimensional. In the multivariate analysis, patients with vertebral fractures, co-morbidity and a lower education level showed to have worse HRQoL. Moderate to high correlations were found between the ECOS-16 score and the other health status questionnaires (0.47–0.82). Reliability: internal consistency (Cronbach's α) was 0.92 and test-retest reliability (ICC) was 0.80. Responsiveness to change: ECOS-16 scores increased according to change perceived by the patient, as well as the effect size (ranges between 1.35 to 0.43), the greater the perception of change in patients' general health status, the greater the changes in patients' scores. The Minimal Clinically Important Difference (MCID) suggested a change of 0.5 points in the ECOS-16 score, representing the least improvement in general health status due to their osteoporosis: "slightly better". Conclusion: ECOS-16 has been proven preliminarily to have good psychometric properties, so that it can be potentially a useful tool to evaluate HRQoL of post-menopausal women with osteoporosis in research and routine clinical practice.